Encore Medical IPO locks at $5 a share after nine S-1 amendments

As seen on the 24/7 Wall St. homepage on November 16, 2026.

IPO TERMS REVISED
Encore Medical, Inc. ENMD · OTCQB
$5–$5 / share
$7M raise 1,400,000 shares

Price fixed at $5 in ninth S-1/A

Nine amendments in, Encore Medical has locked its terms at a flat $5 a share for 1.4 million shares, a $7 million raise headed to the OTCQB rather than a major exchange. Oak Ridge Financial and Network 1 are running the book, so pricing is the next and final step.

Continue ReadingShow less

Encore Medical, Inc. has set a fixed offering price of $5 per share after filing its ninth S-1 amendment, a level of revision that signals how carefully the company and its bankers have worked to find a clearing price the market will accept.

The offering is headed to the OTCQB rather than a major national exchange, which puts it in a tier typically associated with smaller, earlier-stage companies that have not yet met the listing standards of the Nasdaq or NYSE. That destination matters for investors thinking about liquidity and visibility once shares begin trading.

Sponsored

Oak Ridge Financial and Network 1 Financial Securities are running the book as joint underwriters. With terms now fixed and the syndicate in place, pricing is the next and final step before shares are formally issued.

Nine amendments is an unusually long revision process for an offering of this size, reflecting either ongoing negotiations over valuation or continued regulatory review by the SEC. The fact that the price range collapsed to a single point at $5, with no spread between low and high, suggests the final terms were agreed with little remaining flexibility.

Sources

Mentioned: EMI